U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT07481955) titled 'Chlorhexidine and/or Metronidazole Plus FB301 Pre-treatment Trial' on March 15.
Brief Summary: The goal of this study is to evaluate how treatment with FB301 affects the balance of vaginal bacteria in women (aged 18-45) with bacterial vaginosis after pre-treatment with either a vaginal antiseptic wash (chlorhexidine), an oral antibiotic (metronidazole), or both.
The main question it aims to answer is:
Does treatment with FB301, with or without pre-treatment using a vaginal antiseptic (chlorhexidine) or an oral antibiotic (metronidazole), change the balance of vaginal bacteria, measured by the proportion of two key bacteria (Lacto...